ID: 206	RANK: 71	SCORE: 19.399374
<DOC>
<DOCNO> WSJ871102-0124 </DOCNO>
<HL> Lilly Antibiotic Clears FDA</HL>
<DD> 11/02/87</DD>
<SO> WALL STREET JOURNAL (J)</SO>
<IN> LLY
PHARMACEUTICALS, HOSPITAL SUPPLIES, MANAGEMENT (PHA)
FOOD AND DRUG ADMINISTRATION (FDA) </IN>
<DATELINE> INDIANAPOLIS  </DATELINE>
<TEXT>
   Eli Lilly &amp; Co. said the Food and Drug Administration has approved the company's new oral antibiotic, Keftab, for marketing in the U.S. 

   The maker of pharmaceuticals, medical and agricultural products said Keftab is used to treat several types of bacterial infections, including upper and lower respiratory infections, urinary tract infections, and skin and soft-tissue infections. 

   Eli Lilly said it will market the product through its Dista Products Co. division. 

</TEXT>
</DOC>
